Form 4 for ABT Abbott Laboratories
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001415889-25-006788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2025-02-28 | ABT | Morrone Louis H. | EVP | F - Tax | $135.87 | -4,386 | 68.0K | -6% | -$595.9K | |
| 2025-03-04 | 2025-03-03 | ABT | Morrone Louis H. | EVP | S - Sale | $138.17 | -1,111 | 66.9K | -2% | -$153.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2025-02-28 | F | D | 4,386 | $135.87 | 67,989 | D | — | — | |
| 2 | Common | Common shares without par value | 2025-03-03 | S | D | 1,111 | $138.17 | 66,878 | D | — | — |